Mumbai, Nov. 6 -- The board of Cohance Lifesciences at its meeting held on 06 November 2026 has approved proposed equity investment of 26% in the SPV (under incorporation) to be engaged in solar power generation for the purpose of captive consumption of the company's plant operation.

Published by HT Digital Content Services with permission from Capital Market....